MAT2A Antibody

MAT1A and MAT2A are catalytic subunits of methionine adenosyltransferase (MAT), which catalyzes the formation of S-adenosyltransferase for methionine catabolism. Inactivation of MAT1A has been linked to liver disease. In addition, in certain liver cancers, expression of MAT1A is replaced by expression of MAT1B. Overexpression of MAT2A has also been observed in colon cancer, leading to the proposal that MAT2A facilitates cancer cell growth.

MAT1A and MAT2A antibodies are useful tools for cancer research and liver function research.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 2 confirmed species: Human, Mouse.

We have publications tested in 3 applications: IF/IHC, IHC-P, WB.

Showing Publications 1 - 3 of 3.

Publications using NBP1-92100	Applications	Species
Zhang R, Zhang Y, Guo F et al. Knockdown of METTL16 disrupts learning and memory by reducing the stability of MAT2A mRNA Cell death discovery 2022-10-28 [PMID: 36307396] (WB, IF/IHC, Mouse)	WB, IF/IHC	Mouse
Luo H, Song Y, Zhang JA et al. MAT2A facilitates PDCD6 methylation and promotes cell growth under glucose deprivation in cervical cancer Cell death discovery 2022-04-08 [PMID: 35396512] (WB, IF/IHC, Human)	WB, IF/IHC	Human
Wang K, Fang S, Liu Q et al. TGF-b1/p65/MAT2A pathway regulates liver fibrogenesis via intracellular SAM EBioMedicine 2019-03-26 [PMID: 30926424] (IHC-P, Mouse)	IHC-P	Mouse

Array NBP1-92100

• MAT2A Antibodies
• MAT2A Lysate
• MAT2A Proteins
• MAT2A Proteins and Enzyme